For example, it was previously found that decreased expression of GAS5 is associated with poor prognosis of cervical cancer patients44,45 as well as is tumor suppressive in other types of cancer such as breast cancer46,47 and prostate cancer47. Here, GAS5 is linked to cervical carcinoma.